首页> 外文OA文献 >Pre-clinical characterization of GMP grade CCL21-gene modified dendritic cells for application in a phase I trial in Non-Small Cell Lung Cancer

【2h】

Pre-clinical characterization of GMP grade CCL21-gene modified dendritic cells for application in a phase I trial in Non-Small Cell Lung Cancer

机译：GMP级CCL21基因修饰的树突状细胞的临床前表征，用于非小细胞肺癌的I期试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者

展开▼
作者单位

展开▼
年度 2008
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Pre-clinical characterization of GMP grade CCL21-gene modified dendritic cells for application in a phase I trial in Non-Small Cell Lung Cancer [J] . Felicita Baratelli, Hiroko Takedatsu, Saswati Hazra, Journal of Translational Medicine . 2008,第1期

机译：GMP级CCL21基因修饰的树突状细胞的临床前表征，用于非小细胞肺癌的I期试验
2. A randomized phase II study to assess the effect of adjuvant immunotherapy using α-GalCer-pulsed dendritic cells in the patients with completely resected stage II–IIIA non-small cell lung cancer: study protocol for a randomized controlled trial [J] . Hideo Saka, Chiyoe Kitagawa, Yukito Ichinose, Trials . 2017,第1期

机译：一项II期随机研究，评估在完全切除的II–IIIA期非小细胞肺癌患者中使用α-GalCer脉冲树突状细胞进行辅助免疫治疗的效果：一项随机对照试验的研究方案
3. Phase II Study of Modified Carboplatin Plus Weekly Nab-Paclitaxel in Elderly Patients with Non-Small Cell Lung Cancer: North Japan Lung Cancer Study Group Trial 1301 [J] . Miyauchi Eisaku, Inoue Akira, Usui Kazuhiro, The oncologist . 2017,第6期

机译：DEARIED CARBOPLATIN PLUS的II期研究加上老年非小细胞肺癌患者的NAB-PABLITAXEL：北日本肺癌研究组试验1301
4. A Deep Learning-Facilitated Radiomics Solution for the Prediction of Lung Lesion Shrinkage in Non-Small Cell Lung Cancer Trials [C] . Antong Chen, Jennifer Saouaf, Bo Zhou, IEEE International Symposium on Biomedical Imaging . 2020

机译：在非小细胞肺癌试验中用于预测肺病变萎缩的深度学习促进放射组学解决方案
5. Clinical predictive value of pre-clinical cancer models: A study of the predictive value of the in vitro cell line, human xenograft and murine allograft pre-clinical cancer models for phase II clinical trials of cytotoxic cancer drugs [D] . Voskoglou-Nomikos, Theodora 2001

机译：临床前癌症模型的临床预测价值：体外细胞系，人异种移植和小鼠同种异体移植临床前癌症模型对细胞毒性癌症药物II期临床试验的预测价值研究
6. Pre-clinical characterization of GMP grade CCL21-gene modified dendritic cells for application in a phase I trial in Non-Small Cell Lung Cancer [O] . Felicita Baratelli, Hiroko Takedatsu, Saswati Hazra, 2008

机译：GMP级CCL21基因修饰的树突状细胞的临床前表征用于非小细胞肺癌的I期试验
7. Pre-clinical characterization of GMP grade CCL21-gene modified dendritic cells for application in a phase I trial in Non-Small Cell Lung Cancer [O] . Baratelli, Felicita, Takedatsu, Hiroko, Hazra, Saswati, 2008

机译：GMP级CCL21基因修饰的树突状细胞的临床前表征，用于非小细胞肺癌的I期试验
8. Phase 1 Trial of an Immune Checkpoint Inhibitor plus Stereotactic Ablative Radiotherapy in Patients with Inoperable Stage I Non-Small Cell Lung Cancer. [R] . Kelly, K., Monjazeb, A., Daly, M., 2017

机译：免疫检查点抑制剂加立体定向消融放疗治疗不能手术的I期非小细胞肺癌的1期试验。

Pre-clinical characterization of GMP grade CCL21-gene modified dendritic cells for application in a phase I trial in Non-Small Cell Lung Cancer

著录项

引文网络

相似文献

相关主题

期刊订阅